1. Home
  2. ADMA vs WD Comparison

ADMA vs WD Comparison

Compare ADMA & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$10.32

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

HOLD

Current Price

$51.55

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
WD
Founded
2004
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2012
2010

Fundamental Metrics

Financial Performance
Metric
ADMA
WD
Price
$10.32
$51.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$25.67
$76.00
AVG Volume (30 Days)
4.7M
188.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
5.34%
EPS Growth
N/A
N/A
EPS
0.60
1.64
Revenue
$42,219,783.00
$1,234,306,000.00
Revenue This Year
$27.46
$20.60
Revenue Next Year
$22.11
$7.79
P/E Ratio
$17.16
$31.15
Revenue Growth
43.85
8.99
52 Week Low
$7.21
$42.12
52 Week High
$23.98
$90.00

Technical Indicators

Market Signals
Indicator
ADMA
WD
Relative Strength Index (RSI) 39.94 59.59
Support Level $7.21 $48.44
Resistance Level $11.42 $52.44
Average True Range (ATR) 0.48 1.57
MACD 0.10 0.23
Stochastic Oscillator 15.69 70.50

Price Performance

Historical Comparison
ADMA
WD

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Share on Social Networks: